Frontiers | Cellular Therapies and Outpatient Care: from the Basics to Clinics

Cellular Therapies and Outpatient Care: from the Basics to Clinics

24k
Total downloads
99k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 04 Oct 2024

A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia

José Carlos Jaime-Pérez
Jorge Valdespino-Valdes
Andrés Gómez-De León
Renata Valeria Barragán-Longoria
Adriana Dominguez-Villanueva
Olga Graciela Cantú-Rodríguez
César Homero Gutiérrez-Aguirre
David Gómez-Almaguer

doi 10.3389/fimmu.2024.1400610

637 views

CASE REPORT

Published on 20 Sep 2024

Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen

Raya Aliakbar
Olga Manouvakhova
Cindy Wong
Myo Htut
Johannes Pulst-Korenberg
Murali Janakiram
Michael Rosenzweig
Scott R. Goldsmith
Xenos L. Mason

doi 10.3389/fimmu.2024.1444010

1,416 views
1 citation

ORIGINAL RESEARCH

Published on 21 Aug 2024

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4

Doris K. Hansen
Xiaoxiao Lu
Omar Castaneda Puglianini
Sonja Sorensen
Saad Z. Usmani
Eileen Zhang
Stephen Huo
Yan Zhang
Zaina P. Qureshi
Sundar Jagannath

doi 10.3389/fimmu.2024.1408892

1,926 views

REVIEW

Published on 06 Aug 2024

Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration

Scott R. Goldsmith
May San-Rozano
Justine Katindoy
Janet Rattanapichetkul
Michael Rosenzweig

doi 10.3389/fimmu.2024.1423959

936 views

SYSTEMATIC REVIEW

Published on 16 Jul 2024

Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact

Miguel Ángel Prieto del Prado
Francesc Fernández Avilés

doi 10.3389/fimmu.2024.1419186

1,026 views

ORIGINAL RESEARCH

Published on 14 Jun 2024

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma

David G. Frame
Marcus Geer
Salena Kasha
Denise Markstrom
Gianni Scappaticci
Tate Feeney
Andrew Hayduk
Hilary M. Mansoor
Avery Oberfeld
8 more
Monalisa Ghosh

doi 10.3389/fimmu.2024.1403145

1,411 views
1 citation

PERSPECTIVE

Published on 11 Jun 2024

Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement

Maria-Estela Moreno-Martinez
Mireia Riba
Irene García-Cadenas
Albert Esquirol
Marta Yusta
Sara Redondo
Anna De Dios
Jose Manuel Portos
Olga Aso
4 more
Anna Feliu

doi 10.3389/fimmu.2024.1397115

953 views
1 citation

ORIGINAL RESEARCH

Published on 10 Jun 2024

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma

Doris K. Hansen
Binod Dhakal
Mehdi Hamadani
David Dingli
Tania Jain
Carol Ann Huff
Murali Janakiram
Yi-Hsuan Liu
Kevin C. De Braganca
7 more
Krina K. Patel

doi 10.3389/fimmu.2024.1405452

2,145 views

ORIGINAL RESEARCH

Published on 24 May 2024

Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States

Olalekan O. Oluwole
Markqayne D. Ray
Richard M. Zur
Cheryl P. Ferrufino
Brett Doble
Anik R. Patel
S. Pinar Bilir

doi 10.3389/fimmu.2024.1393939

3,777 views

MINI REVIEW

Published on 08 May 2024

Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers

Ariel Perez
Tiba Al Sagheer
George R. Nahas
Yuliya P. L. Linhares

doi 10.3389/fimmu.2024.1412002

2,770 views
1 citation

MINI REVIEW

Published on 26 Apr 2024

Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies

Iñigo Romon
Soledad Gonzalez-Barrera
Carmen Coello de Portugal
Enrique Ocio
Isabel Sampedro

doi 10.3389/fimmu.2024.1366962

1,171 views

REVIEW

Published on 05 Oct 2023

Novel therapies for graft versus host disease with a focus on cell therapies

Robert Zeiser
Olle Ringden
Behnam Sadeghi
Gil Gonen-Yaacovi
Oscar G. Segurado

doi 10.3389/fimmu.2023.1241068

5,258 views
4 citations

Share on

Frontiers in Immunology

Alloimmunity and Transplantation
Nutritional Immunology
Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Health Services
- Cost and Resource Allocation
- 1.6 impact factor
- 1.0 citescore
Frontiers in Medicine
- Pathology
- 3.1 impact factor
- 5.1 citescore
Frontiers in Nutrition
- Nutritional Immunology
- 4.0 impact factor
- 5.2 citescore
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

99kTopic views
71kArticle views
24kArticle downloads

View impact

Submit your idea

Articles

A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia

Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4

Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration

Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma

Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma

Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States

Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers

Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies

Novel therapies for graft versus host disease with a focus on cell therapies

Frontiers in Immunology

Participating Journals

Impact